Prediction of mutations engineered by randomness in H5N1 neuraminidases from influenza a virus

Amino Acids

Volumn 34, Issue 1, 2008, Pages 81-90

  Wu, G ^a   Yan, S ^a  

^a DreamSciTech Consulting   (China)

Author keywords

Influenza; Logistic regression; Mutation; Neuraminidase; Prediction

Indexed keywords

VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

AMINO ACID COMPOSITION; ARTICLE; ARTIFICIAL NEURAL NETWORK; INFLUENZA VIRUS A H5N1; LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RNA GENE; RNA TRANSLATION; VIRUS MUTATION;

AMINO ACIDS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MUTATION; NEURAMINIDASE; PROBABILITY; PROTEIN BIOSYNTHESIS; PROTEIN ENGINEERING;

INFLUENZA A VIRUS;

EID: 38149089523     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-007-0579-z     Document Type: Article

References (119)

1. GM Air LR Ritchie WG Laver PM Colman 1985 Gene and protein sequence of an influenza neuraminidase with hemagglutinin activity Virology 145 117 122
2. IW Althaus JJ Chou AJ Gonzales MR Diebel KC Chou FJ Kezdy DL Romero PA Aristoff WG Tarpley F Reusser 1993a Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E J Biol Chem 268 6119 6124
3. IW Althaus JJ Chou AJ Gonzales MR Diebel KC Chou FJ Kezdy DL Romero PA Aristoff WG Tarpley F Reusser 1993b Kinetic studies with the nonnucleoside HIV-1 reverse transcriptase inhibitor U-88204E Biochemistry 32 6548 6554
4. IW Althaus AJ Gonzales JJ Chou MR Diebel KC Chou FJ Kezdy DL Romero PA Aristoff WG Tarpley F Reusser 1993c The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase J Biol Chem 268 14875 14880
5. K Bragstad PH Jorgensen KJ Handberg S Mellergaard S Corbet A Fomsgaard 2005 New avian influenza A virus subtype combination H5N7 identified in Danish mallard ducks Virus Res 109 181 190
6. L Campitelli E Mogavero MA De Marco M Delogu S Puzelli F Frezza M Facchini C Chiapponi E Foni P Cordioli R Webby G Barigazzi RG Webster I Donatelli 2004 Interspecies transmission of an H7N3 influenza virus from wild birds to intensively reared domestic poultry in Italy Virology 323 24 36
7. H Chen GJ Smith KS Li J Wang XH Fan JM Rayner D Vijaykrishna JX Zhang LJ Zhang CT Guo CL Cheung KM Xu L Duan K Huang K Qin YH Leung WL Wu HR Lu Y Chen NS Xia TS Naipospos KY Yuen SS Hassan S Bahri TD Nguyen RG Webster JS Peiris Y Guan 2006 Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control Proc Natl Acad Sci USA 103 2845 2850
8. KC Chou 1993 A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins J Biol Chem 268 16938 16948
9. JJ Chou 1993a A formulation for correlating properties of peptides and its application to predicting human immunodeficiency virus protease-cleavable sites in proteins Biopolymers 33 1405 1414
10. JJ Chou 1993b Predicting cleavability of peptide sequences by HIV protease via correlation-angle approach J Protein Chem 12 291 302
11. KC Chou 1996 Prediction of HIV protease cleavage sites in proteins Anal Biochem 233 1 14
12. KC Chou 2004a Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor Biochem Biophys Res Commun 319 433 438
13. KC Chou 2004b Insights from modelling the tertiary structure of BACE2 J Proteome Res 3 1069 1072
14. KC Chou 2004c Molecular therapeutic target for type-2 diabetes J Proteome Res 3 1284 1288
15. KC Chou 2004d Structural bioinformatics and its impact to biomedical science Curr Med Chem 11 2105 2134
16. KC Chou 2004e Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5 Biochem Biophys Res Commun 316 636 642
17. KC Chou 2005 Modeling the tertiary structure of human cathepsin-E Biochem Biophys Res Commun 331 56 60
18. KC Chou D Jones RL Heinrikson 1997 Prediction of the tertiary structure and substrate binding site of caspase-8 FEBS Lett 419 49 54
19. KC Chou FJ Kezdy F Reusser 1994 Steady-state inhibition kinetics of processive nucleic acid polymerases and nucleases Anal Biochem 221 217 230
20. KC Chou AG Tomasselli RL Heinrikson 2000 Prediction of the tertiary structure of a caspase-9/inhibitor complex FEBS Lett 470 249 256
21. KC Chou KD Watenpaugh RL Heinrikson 1999 A model of the complex between cyclin-dependent kinase 5(Cdk5) and the activation domain of neuronal Cdk5 activator Biochem Biophys Res Commun 259 420 428
22. KC Chou DQ Wei QS Du S Sirois WZ Zhong 2006 Progress in computational approach to drug development against SARS Curr Med Chem 13 3263 3270
23. KC Chou DQ Wei WZ Zhong 2003 Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS Biochem Biophys Res Comm 308 148 151 Erratum: ibid, 2003, 310, 675
24. M Dayhoff R Schwartz B Orcutt 1978 A model of evolutionary change in protein Atlas Protein Seq Struct 5 345 352
25. RO Donis WJ Bean Y Kawaoka RG Webster 1989 Distinct lineages of influenza virus H4 hemagglutinin genes in different regions of the world Virology 169 408 417
26. NR Draper H Smith 1981 Applied regression analysis 2 Wiley New York
27. QS Du PG Mezey KC Chou 2005 Heuristic molecular lipophilicity potential (HMLP): a 2D-QSAR study to LADH of molecular family pyrazole and derivatives J Comput Chem 26 461 470
28. QS Du H Sun KC Chou 2007 Inhibitor design for SARS coronavirus main protease based on "distorted key theory" Med Chem 3 1 6
29. BS Everitt 1999 Chance rules: an informal guide to probability, risk, and statistics Springer New York
30. W Feller 1968 An introduction to probability theory and its applications 3 I Wiley New York
31. DF Feng MS Johnson RF Doolittle 1985 Aligning amino acid sequences: comparison of commonly used methods J Mol Evol 21 112 125
32. WM Fitch RM Bush CA Bender NJ Cox 1997 Long term trends in the evolution of H(3) HA1 human influenza type A Proc Natl Acad Sci USA 94 7712 7718
33. E Garman G Laver 2004 Controlling influenza by inhibiting the virus's neuraminidase Curr Drug Targ 5 119 136
34. N Gao S Yan G Wu 2006 Pattern of positions sensitive to mutations in human haemoglobin α-chain Protein Pept Lett 13 101 107
35. WN Gao DQ Wei Y Li H Gao WR Xu AX Li KC Chou 2007 Agaritine and its derivatives are potential inhibitors against HIV proteases Med Chem 3 221 226
36. A Gottschalk 1957 The specific enzyme of influenza virus and Vibrio cholerae Biochim Biophys Acta 23 645 646
37. Y Guan LL Poon CY Cheung TM Ellis W Lim AS Lipatov KH Chan KM Sturm-Ramirez CL Cheung YH Leung KY Yuen RG Webster JS Peiris 2004 H5N1 influenza: a protean pandemic threat Proc Natl Acad Sci USA 101 8156 8161
38. VR Harley CW Ward PJ Hudson 1989 Molecular cloning and analysis of the N5 neuraminidase subtype from an avian influenza virus Virology 169 239 243
39. MJR Healy 1979 Outliers in clinical chemistry quality-control schemes Clin Chem 25 675 677
40. MR Hilleman 2002 Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control Vaccine 20 3068 3087
41. E Hoffmann J Stech I Leneva S Krauss C Scholtissek PS Chin M Peiris KF Shortridge RG Webster 2000 Characterization of the influenza A virus gene pool in avian species in southern China: was H6N1 a derivative or a precursor of H5N1? Virology 74 6309 6315
42. M Hochgürtel H Kroth D Piecha MW Hofmann C Nicolau S Krause O Schaaf G Sonnenmoser AV Eliseev 2002 Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries Proc Natl Acad Sci USA 99 3382 3387
43. DW Hosmer Jr S Lemeshow 2000 Applied logistic regression 2 Wiley New York
44. Influenza virus resources (2006) http://www.ncbi.nlm.nih.gov/genomes/FLU/ Database/multiple.cgi
45. S Karlin G Ghandour 1985 Multiple-alphabet amino acid sequence comparisons of the immunoglobulin kappa-chain constant domain Proc Natl Acad Sci USA 82 8597 8601
46. S Krauss D Walker SP Pryor L Niles L Chenghong VS Hinshaw RG Webster 2004 Influenza A viruses of migrating wild aquatic birds in North America Vector Borne Zoonotic Dis 4 177 189
47. CW Lee DL Suarez TM Tumpey HW Sung YK Kwon YJ Lee JG Choi SJ Joh MC Kim EK Lee JM Park X Lu JM Katz E Spackman DE Swayne JH Kim 2005 Characterization of highly pathogenic H5N1 avian influenza A viruses isolated from South Korea J Virol 79 3692 3702
48. L Li DQ Wei JF Wang KC Chou 2007 Computational studies of the binding mechanism of calmodulin with chrysin Biochem Biophys Res Commun 358 1102 1107
49. M Liu S He D Walker N Zhou DR Perez B Mo F Li X Huang RG Webster RJ Webby 2003 The influenza virus gene pool in a poultry market in South central China Virology 305 267 275
50. T Müller R Spang M Vingron 2002 Estimating amino acid substitution models: a comparison of Dayhoff's estimator, the resolvent approach and a maximum likelihood method Mol Biol Evol 19 8 13
51. J Oxford S Balasingam R Lambkin 2004 A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community J Antimicrob Chemother 53 133 136
52. JC Paulson 1985 Interactions of animal viruses with cell surface receptors M Connor The receptors Academic Press Orlando 131 219
53. C Rohm T Horimoto Y Kawaoka J Suss RG Webster 1995 Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology 209 664 670
54. E Schreier H Roeske G Driesel U Kunkel DR Petzold R Berlinghoff S Michel 1988 Complete nucleotide sequence of the neuraminidase gene of the human influenza virus A/Chile/1/83 (H1N1) Arch Virol 99 271 276
55. T Suzuki T Takahashi T Saito CT Guo KI Hidari D Miyamoto Y Suzuki 2004 Evolutional analysis of human influenza A virus N2 neuraminidase genes based on the transition of the low-pH stability of sialidase activity FEBS Lett 557 228 232
56. TB Thompson KC Chou C Zheng 1995 Neural network prediction of the HIV-1 protease cleavage sites J Theor Biol 177 369 379
57. JF Wang DQ Wei L Li SY Zheng YX Li KC Chou 2007a 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design Biochem Biophys Res Commun 355 513 519 Corrigendum: ibid, 2007, 357, 330
58. JF Wang DQ Wei Y Lin YH Wang HL Du KC Chou 2007c Insights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP Biochem Biophys Res Commun 359 323 329
59. SQ Wang QS Du KC Chou 2007b Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases Biochem Biophys Res Commun 354 634 640
60. DQ Wei QS Du H Sun KC Chou 2006 Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands Biochem Biophys Res Commun 344 1048 1055
61. H Wei R Zhang C Wang H Zheng KC Chou DQ Wei 2007 Molecular insights of SAH enzyme catalysis and their implication for inhibitor design J Theor Biol 244 692 702
62. G Wu 1997 An explanation for failure to predict cyclosporine area under the curve using a limited sampling strategy: a beginner's second note Pharmacol Res 35 547 552
63. 2 affinity Comp Haematol Int 9 148 151
64. G Wu 2000a Frequency and Markov chain analysis of amino-acid sequence of human glutathione reductase Biochem Biophys Res Commun 268 823 826
65. G Wu 2000b Frequency and Markov chain analysis of amino-acid sequence of human tumor necrosis factor Cancer Lett 153 145 150
66. G Wu 2000c Frequency and Markov chain analysis of amino-acid sequences of mouse p53 Human Exper Toxicol 19 535 539
67. G Wu 2000d Frequency and Markov chain analysis of the amino acid sequence of human alcohol dehydrogenase α-chain Alcohol Alcohol 35 302 306
68. G Wu 2000e Frequency and Markov chain analysis of the amino- acid sequence of sheep p53 protein J Biochem Mol Biol Biophys 4 179 185
69. G Wu 2000f The first, second and third order Markov chain analysis on amino acids sequence of human tyrosine aminotransferase and its variant causing tyrosinemia type II Pediatr Relat Top 39 37 47
70. G Wu 2000g The first, second, third and fourth order Markov chain analysis on amino acids sequence of human dopamine β-hydroxylase Mol Psychiatry 5 448 451
71. G Wu M Baraldo F Pea P Cossettini M Furlanut 1995 Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods Pharmacol Res 32 355 362
72. G Wu P Cossettini M Furlanut 1996 Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by one-, two- and three-compartment models using Bayesian and non-linear least squares methods Pharmacol Res 34 47 57
73. G Wu S Yan 2000a Frequency and Markov chain analysis of amino-acids sequence of human platelet-activating factor acetylhydrolase α-subunit and its variant causing the lissencephaly syndrome Pediatr Relat Top 39 513 526
74. G Wu S Yan 2000b Prediction of two- and three-amino acid sequence of human acute myeloid leukemia 1 protein from its amino acid composition Comp Haematol Int 10 85 89
75. G Wu S Yan 2000c Prediction of two- and three-amino-acid sequences of Citrobacter Freundii β-lactamase from its amino acid composition J Mol Microbiol Biotechnol 2 277 281
76. G Wu S Yan 2000d Prediction of distributions of amino acids and amino acid pairs in human haemoglobin α-chain and its seven variants causing α-thalassemia from their occurrences according to the random mechanism Comp Haematol Int 10 80 84
77. G Wu S Yan 2001a Frequency and Markov chain analysis of amino-acid sequences of human connective tissue growth factor J Mol Model 5 120 124
78. G Wu S Yan 2001b Prediction of presence and absence of two- and three-amino-acid sequence of human monoamine oxidase B from its amino acid composition according to the random mechanism Biomol Eng 18 23 27
79. G Wu S Yan 2001c Prediction of presence and absence of two- and three-amino-acid sequence of human tyrosinase from their amino acid composition and related changes in human tyrosinase variant causing oculocutaneous albinism Pediatr Relat Top 40 153 166
80. G Wu S Yan 2001d Analysis of distributions of amino acids, amino acid pairs and triplets in human insulin precursor and four variants from their occurrences according to the random mechanism J Biochem Mol Biol Biophys 5 293 300
81. G Wu S Yan 2001e Analysis of distributions of amino acids and amino acid pairs in human tumor necrosis factor precursor and its eight variants according to random mechanism J Mol Model 7 318 323
82. G Wu S Yan 2002a Determination of amino acid pairs sensitive to variants in human low-density lipoprotein receptor precursor by means of a random approach J Biochem Mol Biol Biophys 6 401 406
83. G Wu S Yan 2002b Estimation of amino acid pairs sensitive to variants in human phenylalanine hydroxylase protein by means of a random approach Peptides 23 2085 2090
84. G Wu S Yan 2002c Random analysis of presence and absence of two- and three-amino-acid sequences and distributions of amino acids, two- and three-amino-acid sequences in bovine p53 protein Mol Biol Today 3 31 37
85. G Wu S Yan 2002d Analysis of distributions of amino acids in the primary structure of apoptosis regulator Bcl-2 family according to the random mechanism J Biochem Mol Biol Biophys 6 407 414
86. G Wu S Yan 2002e Analysis of distributions of amino acids in the primary structure of tumor suppressor p53 family according to the random mechanism J Mol Model 8 191 198
87. G Wu S Yan 2002f Randomness in the primary structure of protein: methods and implications Mol Biol Today 3 55 69
88. G Wu S Yan 2003a Analysis of amino acid pairs sensitive to variants in human collagen α5(IV) chain precursor by means of a random approach Peptides 24 347 352
89. G Wu S Yan 2003b Determination of amino acid pairs in human haemoglobulin α-chain sensitive to variants by means of a random approach Comp Clin Pathol 12 21 25
90. G Wu S Yan 2003c Determination of amino acid pairs in human p53 protein sensitive to mutations/variants by means of a random approach J Mol Model 9 337 341
91. G Wu S Yan 2003d Determination of amino acid pairs in Von Hippel-Lindau disease tumour suppressor (G7 protein) sensitive to variants by means of a random approach J Appl Res 3 512 520
92. G Wu S Yan 2003e Determination of amino acid pairs sensitive to variants in human β-glucocerebrosidase by means of a random approach Protein Eng 16 195 199
93. G Wu S Yan 2003f Determination of amino acid pairs sensitive to variants in human Bruton's tyrosine kinase by means of a random approach Mol Simul 29 249 254
94. G Wu S Yan 2003g Determination of amino acid pairs sensitive to variants in human coagulation factor IX precursor by means of a random approach J Biomed Sci 10 451 454
95. G Wu S Yan 2003h Prediction of amino acid pairs sensitive to mutations in the spike protein from SARS related coronavirus Peptides 24 1837 1845
96. G Wu S Yan 2004a Amino acid pairs sensitive to variants in human collagen α1(I) chain precursor EXCLI J 3 10 19
97. G Wu S Yan 2004b Determination of amino acid pairs sensitive to variants in human copper-transporting ATPase 2 Biochem Biophys Res Commun 319 27 31
98. G Wu S Yan 2004c Fate of 130 hemagglutinins from different influenza A viruses Biochem Biophys Res Commun 317 917 924
99. G Wu S Yan 2004d Potential targets for anti-SARS drugs in the structural proteins from SARS related coronavirus Peptides 25 901 908
100. G Wu S Yan 2004e Susceptible amino acid pairs in variants of human collagen α1(III) chain precursor EXCLI J 3 20 28
101. G Wu S Yan 2004f Determination of sensitive positions to mutations in human p53 protein Biochem Biophys Res Commun 321 313 319
102. G Wu S Yan 2005a Amino acid pairs susceptible to variants in human protein C precursor Protein Pept Lett 10 491 494
103. G Wu S Yan 2005b Mutation features of 215 polymerase proteins from different influenza A viruses Med Sci Monit 11 BR367 BR372
104. G Wu S Yan 2005c Reasoning of spike glycoproteins being more vulnerable to mutations among 158 coronavirus proteins from different species J Mol Model 11 8 16
105. G Wu S Yan 2005d Timing of mutation in hemagglutinins from influenza A virus by means of unpredictable portion of amino-acid pair and fast Fourier transform Biochem Biophys Res Commun 333 70 78
106. G Wu S Yan 2005e Searching of main cause leading to severe influenza A virus mutations and consequently to influenza pandemics/epidemics Am J Infect Dis 1 116 123
107. G Wu S Yan 2005f Prediction of mutation trend in hemagglutinins and neuraminidases from influenza A viruses by means of cross-impact analysis Biochem Biophys Res Commun 326 475 482
108. G Wu S Yan 2005g Determination of mutation trend in proteins by means of translation probability between RNA codes and mutated amino acids Biochem Biophys Res Commun 337 692 700
109. G Wu S Yan 2006a Fate of influenza A virus proteins Protein Pept Lett 13 377 384
110. G Wu S Yan 2006b Mutation trend of hemagglutinin of influenza A virus: a review from computational mutation viewpoint Acta Pharmacol Sin 27 513 526
111. G Wu S Yan 2006c Timing of mutation in hemagglutinins from influenza A virus by means of amino-acid distribution rank and fast Fourier transform Protein Pept Lett 13 143 148
112. G Wu S Yan 2006d Determination of mutation trend in hemagglutinins by means of translation probability between RNA codons and mutated amino acids Protein Pept Lett 13 601 609
113. G Wu S Yan 2006e Prediction of possible mutations in H5N1 hemagglutinins of influenza A virus by means of logistic regression Comp Clin Pathol 15 255 261
114. G Wu S Yan 2006f Prediction of mutations in H5N1 hemagglutinins from influenza A virus Protein Pept Lett 13 971 976
115. G Wu S Yan 2007a Improvement of model for prediction of hemagglutinin mutations in H5N1 influenza viruses with distinguishing of arginine, leucine and serine Protein Pept Lett 14 191 196
116. G Wu S Yan 2007b Translation probability between RNA codons and translated amino acids, and its applications to protein mutations MH Ostrovskiy Leading-edge messenger RNA research communications Nova Science Publishers New York
117. G Wu S Yan 2007c Improvement of prediction of mutation positions in H5N1 hemagglutinins of influenza A virus using neural network with distinguishing of arginine, leucine and serine Protein Pept Lett 14 465 470
118. Wu G, Yan S (2007d) Prediction of mutations initiated by internal power in H3N2 hemagglutinins of influenza A virus from North America. Int J Pept Res Ther ( http://dx.doi.org/10.1007/s10989-007-9104-1 )
119. MC Zambon 1999 Epidemiology and pathogenesis of influenza J Antimicrob Chemother 44 Suppl B 3 9